Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

Presentation CHIP at ACC 2018

Update on PCI for LMCA and Multivessel Disease

Presenter: Gregg W. Stone

March 09, 2018

Presentation CHIP Florida 2017

Multivessel Disease and Low EF Case

Presenter: Raja Hatem

January 21, 2017

Presentation

Second- vs First-Generation DES in Multivessel Disease With Left Main Stenosis

Presenter: Carlos Haiek

March 14, 2016

Presentation

EES vs CABG for Patients With Diabetes and Multivessel Disease

Presenter: Sripal Bangalore

July 30, 2015

Presentation BRS 2015

Multivessel and diffuse disease case #2

Presenter: Jochen W?hrle

February 10, 2015

Presentation TCT 2013

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet

January 31, 2013

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

Presenter: Bo Xu, Yuejin Yang, Yaling Han, Bao Li, Qiang Liu, Guoying Zhu, Junyu Cui, Lang Li, Shuzheng Lu

January 31, 2013

Presentation TCT 2012

Multivessel Disease 1: Final Five-Year SYNTAX Results in the MVD Cohort

Presenter: A. Pieter Kappetein

October 22, 2012

Presentation TCT Russia 2012

DES in Complex Multivessel Disease

Presenter: Gregg W. Stone

May 28, 2012

Advertisement

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Update on PCI for LMCA and Multivessel Disease

Multivessel Disease and Low EF Case

Second- vs First-Generation DES in Multivessel Disease With Left Main Stenosis

EES vs CABG for Patients With Diabetes and Multivessel Disease

Multivessel and diffuse disease case #2

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

Multivessel Disease 1: Final Five-Year SYNTAX Results in the MVD Cohort

DES in Complex Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content